Maria Quillard
(408) 879-4988

XILINX REPORTS FISCAL 1997 SECOND QUARTER RESULTS

SAN JOSE, CA, OCTOBER 15, 1996 -- Xilinx, Inc. (NASDAQ:XLNX) reported that revenues and earnings declined from both the prior quarter and the year ago period. Revenues for the September-ending quarter fell to $130.6 million, a decrease of 13.1% from the $150.2 million of the immediately preceding quarter and 7.5% from the $141.2 million reported one year ago. Operating income decreased to $29.5 million, while net income fell to $21.2 million, or $0.27 per share. Excluding the impact of the $5.0 million ($0.04 per share) write-off of the XC8100 antifuse product family, operating income decreased 30% from $34.5 million from the previous quarter and net income fell 24% from $24.6 million, or $0.31 per share. Compared to the year ago period, operating income, before consideration of the write-off, declined 25% from $45.7 million, and net income fell 17% from $29.8 million, or $0.37 per share.

"The September quarter was a difficult quarter for the overall programmable logic industry and Xilinx in particular," stated Mr. Wim Roelandts, Xilinx's chief executive officer. "Xilinx revenue declined in both the domestic direct and distribution channels by approximately 14%, as well as in the international channel by nearly 12%. Revenues from our ten largest customers were down by almost $10M compared to last quarter. This revenue shortfall we believe can be attributed to several factors, including increased pressure from selected customers to reduce their own inventory, a seasonably weaker summer quarter in Europe and new customer programs that have not ramped as quickly as initially forecasted."

Revenues from all product families were down this quarter with the exception of the newest, cost-optimized XC5200 family, which comprised 6% of total revenue. "We understand the importance of new products to Xilinx future revenues. We are encouraged by the nearly 1,400 new software seats that we sold this quarter, 70% of which are versions of our new shrink-wrapped, low-cost Foundation software. We are also optimistic that our new XC9500 and XC4000EX families will provide meaningful contributions to revenues before our fiscal year end," Roelandts stated.

Net bookings for the September quarter were more than 10% below the June ending quarter. U.S. distribution resales, which were at expected levels for July and August, weakened during the end of September. "We are, however, encouraged by the stronger bookings momentum observed in the first two weeks of October," concluded Roelandts.

Certain statements in this press release are forward looking. Actual results could differ materially. Among the factors that could cause actual results to differ are the following: availability of components, the lack of visibility into our customers' programmable logic inventory levels, dependence on third party wafer suppliers, concentration of bookings and shipments at the end of the fiscal quarter, the timely availability and acceptance of new products, the impact of competitive products and pricing, and other risks listed on pages 8-11 of Xilinx's 10Q for the period ended June 29, 1996, and in other SEC filings.

Founded in 1984, Xilinx is the world's largest supplier of programmable logic solutions comprising industry leading device architectures and world class design software. Headquartered in San Jose, Calif., the company pioneered the market for field programmable gate array (FPGA) semiconductor devices that provide high integration and quick time-to-market for electronic equipment manufacturers in the computer, peripherals, telecommunications, networking, industrial control, instrumentation, and high-reliability/military markets.

XILINX, INC

Summary Consolidated Financial Statements (Thousands except per share amounts)
(Unaudited) Three months ended Six months ended
Sep. 28,
1996
Sep. 30,
1995
Jun. 29,
1996
Sep. 28,
1996
Sep. 30,
1995
CONSOLIDATED STATEMENT OF INCOME
Revenues $ 130,579 $ 141,212 $ 150,200 $ 280,779 $ 266,972
Cost of revenues 50,658 51,614 53,325 103,983 100,120
Write-off of XC8100 product family (1) 5,000 - - 5,000 -
Research and development 16,748 16,652 17,837 34,585 31,505
Marketing, general and administrative 28,709 27,271 29,548 58,257 52,237
Operating income before non-recurring charges 29,464 45,675 49,490 78,954 83,110
Non-recurring charges (2) - - - - 19,366
Operating income (1) (2) 29,464 45,675 49,490 78,954 63,744
Interest and other income, net 1,970 1,295 885 2,855 3,095
Income before taxes (2) 31,434 46,970 50,375 81,809 66,839
Provision for income taxes 10,216 17,144 17,883 28,099 31,465
Net income (1) (2) $ 21,218 $ 29,826 $ 32,492 $ 53,710 $ 35,374
Net income per share (1) (2) $ .27 $ .37 $ .41 $ .68 $ .45
Weighted average common and common and common
equivalent shares outstanding

(1) The results for the three month period ended September 28, 1996 include a $5.0 million write-off of the Company's XC8100 product family. Excluding the impact of the XC8100 write-off, operating income, net income and net income per share were $34.5 million, $24.6 million and $0.31 respectively for the three months ended September 28, 1996 and $84.0 million, $57.1 million and $0.72, respectively for the six month period ended September 28, 1996.

(2) The results for the six month period ended September 30, 1995 include a $19.4 million write-off of in-process technology relating to the purchase
of NeoCAD, Inc. Excluding the impact of the write-off in-process technology, income before taxes, net income and net income per share were $86.2
million, $54.7 million and $0.70 respectively for the three month period ended September 30, 1995.

Sep. 28,
1996
Mar. 30,
1996
CONSOLIDATED BALANCE SHEET
Current assets
Cash, cash equivalents and short term investments $ 423,484 $ 377,961
Accounts receivable 67,375 79,528
Inventories 63,407 39,238
Deferred income taxes and other current assets 36,949 41,979
Total current assets 591,215 538,706
Property, plant and equipment, net 89,524 82,638
Restricted investments 36,228 36,212
Investment in joint venture 35,200 34,316
Advances for wafer purchases 30,000 -
Developed technology and other assets 27,546 29,008
Total assets $ 809,713 $ 720,880
Current liabilities
Accounts payable, accrued
liabilities and deferred income $ 120,038 $ 101,650
Current obligations under capital leases 508 986
Total current liabilities 120,546 102,636
Long-term debt 250,000 250,000
Stockholders' equity
Common stock and additional paid-in capital 117,952 100,739
Retained earnings 321,215 267,505
Total stockholders' equity 439,167 368,244
Total liabilities and stockholders' equity $ 809,713 $ 720,880

© 1998 Xilinx, Inc. All rights reserved
Trademarks and Patents